Tusseval MuCulcotic syrup based on Bromexin 4 mg/5 ml 250 ml

Tusval MuCulcotic Syrup based on Bromexine 4 mg/5 ml syrup 250 ml

pharmacotherapeutic category:

Mucomculotic syrup for cough

Active principles:

100 ml of syrup contain: Bromexina hydrochloride 80 mg (equal to Brom Exina 73 mg) (1 teaspoon from you ', equal to 5 ml, contains: Bromexina cl Orhydrate 4 mg). < BR>

Excipients:

Tartaric acid, benzoic acid, Carmellosa sodium, glycerol, sorbito liquido, ethanol (96%), aroma all fruits, sodium hydroxide, water purified.

indications:

treatment of secretion disorders in acute and chronic respiratory affections.

contraindications/Eff.secondar: < BR>

hypersensitivity to the active ingredient or to any of the excipients.

in case of hereditary conditions that can be incompatible with one of the excipients.

p>

there are no absolute contraindications, but the N patients with gastroduodenal ulcer, if the use recommended After consulting the doctor.

contraindicated during breastfeeding.

dosage:

The following dosages except for different medical prescription are recommended.

adults: 5-10 ml 3 times a day ( = 24 mg die).

in adults, to the urges or treatment, it may be necessary to increase the total dose Thu Rnaliera up to 48 mg (60 ml) divided three times. BR>

Pediatric population.

Children aged over 2 years: 2.5 - 5 ml 3 times a day (= 12 mg die).

way of administration:

The intake of the drug after meals is recommended.

The syrup can be administered to diabetics and children , does not contain fructose or sucrose.

do not exceed recommended doses. no particular condition of conservation.

warnings:

the Treatment with the drug involves an increase in Bro nchial secretion (this favors expectoration).

Cases of serious skin reactions have been reported such as Erythema Multiform, Steve NS-Johnson's Syndrome (SJS) /toxic epidermal necrolysis (Ten) and generalized acute exant pustolosis (AGEP) associated with the administration of B Romexin hydrochloride.

If there are symptoms or self -progressive skin signs (sometimes associated with vesicles or Lessons of the mucosa), the treatment with bromexine hydrochloride must be interrupted immediate mind and a doctor must be consulted. : 12PT; "> in children of age eriore at 2 years. physiological of the respiratory tract.

they must therefore not be USA In children of age of less than 2 years.

do not use for protracted treatments.

after a short period of treatment without appreciable results to conduct further investigations.

The medicine contains sorbitol.

interactions:

no clinically relevant interactions have been reported with other medicines.
< /p>

undesirable effects:

cases of diarrhea, nausea, vomiting, and cases of other slight gastrointestinal disorders have been reported.

disorders of the Immune system.

rare: hypersensitivity reactions; Not known: anaphylactic reactions, TR to which anaphylactic shock, angioedema and itching.

respiratory, chest and mediastinic pathologies. BR>

pathologists and of the skin and subcutaneous tissue.

rare: rash, urticaria; Not no ta: serious adverse skin reactions (including Eritma Multiform, Sinndro Me by Stevens-Johnson/Toxic epidermal necrolysis and generalized acute exanthem atica). of reporting.

pregnancy and breastfeeding:

use the product in cases of effective need under the direct such as the doctor.

The results of the preclinical studies and the clinical use of the drug did not show negative effects in pregnancy. Particularly in the first quarter.

since the drug passes into breast milk avoid administration in case of breastfeeding.